Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 73

1.

Mining Outcome-relevant Brain Imaging Genetic Associations via Three-way Sparse Canonical Correlation Analysis in Alzheimer's Disease.

Hao X, Li C, Du L, Yao X, Yan J, Risacher SL, Saykin AJ, Shen L, Zhang D; Alzheimer’s Disease Neuroimaging Initiative..

Sci Rep. 2017 Mar 14;7:44272. doi: 10.1038/srep44272.

2.

Robust Identification of Alzheimer's Disease subtypes based on cortical atrophy patterns.

Park JY, Na HK, Kim S, Kim H, Kim HJ, Seo SW, Na DL, Han CE, Seong JK; Alzheimer’s Disease Neuroimaging Initiative..

Sci Rep. 2017 Mar 9;7:43270. doi: 10.1038/srep43270.

3.

Longitudinal measurement and hierarchical classification framework for the prediction of Alzheimer's disease.

Huang M, Yang W, Feng Q, Chen W; Alzheimer’s Disease Neuroimaging Initiative..

Sci Rep. 2017 Jan 12;7:39880. doi: 10.1038/srep39880.

4.

Multimodal characterization of older APOE2 carriers reveals selective reduction of amyloid load.

Grothe MJ, Villeneuve S, Dyrba M, Bartrés-Faz D, Wirth M; Alzheimer's Disease Neuroimaging Initiative..

Neurology. 2017 Feb 7;88(6):569-576. doi: 10.1212/WNL.0000000000003585. Epub 2017 Jan 6.

PMID:
28062720
5.

Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer's pathology.

Schmitz TW, Nathan Spreng R; Alzheimer's Disease Neuroimaging Initiative..

Nat Commun. 2016 Nov 4;7:13249. doi: 10.1038/ncomms13249.

6.

Polygenic risk of Alzheimer disease is associated with early- and late-life processes.

Mormino EC, Sperling RA, Holmes AJ, Buckner RL, De Jager PL, Smoller JW, Sabuncu MR; Alzheimer's Disease Neuroimaging Initiative..

Neurology. 2016 Aug 2;87(5):481-8. doi: 10.1212/WNL.0000000000002922. Epub 2016 Jul 6.

PMID:
27385740
7.

Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis.

Iturria-Medina Y, Sotero RC, Toussaint PJ, Mateos-Pérez JM, Evans AC; Alzheimer’s Disease Neuroimaging Initiative..

Nat Commun. 2016 Jun 21;7:11934. doi: 10.1038/ncomms11934.

8.

A semi-mechanism approach based on MRI and proteomics for prediction of conversion from mild cognitive impairment to Alzheimer's disease.

Liu H, Zhou X, Jiang H, He H, Liu X; Alzheimer’s Disease Neuroimaging Initiative..

Sci Rep. 2016 Jun 7;6:26712. doi: 10.1038/srep26712.

9.

Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer's disease cohorts.

Tan L, Wang HF, Tan MS, Tan CC, Zhu XC, Miao D, Yu WJ, Jiang T, Tan L, Yu JT; Alzheimer’s Disease Neuroimaging Initiative..

Sci Rep. 2016 May 27;6:26027. doi: 10.1038/srep26027.

10.

Accelerating rates of cognitive decline and imaging markers associated with β-amyloid pathology.

Insel PS, Mattsson N, Mackin RS, Schöll M, Nosheny RL, Tosun D, Donohue MC, Aisen PS, Jagust WJ, Weiner MW; Alzheimer's Disease Neuroimaging Initiative..

Neurology. 2016 May 17;86(20):1887-96. doi: 10.1212/WNL.0000000000002683. Epub 2016 Apr 15.

11.

The impact of PICALM genetic variations on reserve capacity of posterior cingulate in AD continuum.

Xu W, Wang HF, Tan L, Tan MS, Tan CC, Zhu XC, Miao D, Yu WJ, Jiang T, Tan L, Yu JT; Alzheimer’s Disease Neuroimaging Initiative Group..

Sci Rep. 2016 Apr 27;6:24480. doi: 10.1038/srep24480.

12.

Better verbal memory in women than men in MCI despite similar levels of hippocampal atrophy.

Sundermann EE, Biegon A, Rubin LH, Lipton RB, Mowrey W, Landau S, Maki PM; Alzheimer's Disease Neuroimaging Initiative..

Neurology. 2016 Apr 12;86(15):1368-76. doi: 10.1212/WNL.0000000000002570. Epub 2016 Mar 16.

13.

Alzheimer's Disease Assessment Scale-Cognitive subscale variants in mild cognitive impairment and mild Alzheimer's disease: change over time and the effect of enrichment strategies.

Podhorna J, Krahnke T, Shear M, Harrison JE; Alzheimer’s Disease Neuroimaging Initiative..

Alzheimers Res Ther. 2016 Feb 12;8:8. doi: 10.1186/s13195-016-0170-5.

14.

Reference tissue normalization in longitudinal (18)F-florbetapir positron emission tomography of late mild cognitive impairment.

Shokouhi S, Mckay JW, Baker SL, Kang H, Brill AB, Gwirtsman HE, Riddle WR, Claassen DO, Rogers BP; Alzheimer’s Disease Neuroimaging Initiative..

Alzheimers Res Ther. 2016 Jan 15;8:2. doi: 10.1186/s13195-016-0172-3.

15.

Periventricular hyperintensities are associated with elevated cerebral amyloid.

Marnane M, Al-Jawadi OO, Mortazavi S, Pogorzelec KJ, Wang BW, Feldman HH, Hsiung GY; Alzheimer's Disease Neuroimaging Initiative..

Neurology. 2016 Feb 9;86(6):535-43. doi: 10.1212/WNL.0000000000002352. Epub 2016 Jan 8.

16.

Highly adaptive tests for group differences in brain functional connectivity.

Kim J, Pan W; Alzheimer's Disease Neuroimaging Initiative..

Neuroimage Clin. 2015 Oct 22;9:625-39. doi: 10.1016/j.nicl.2015.10.004. eCollection 2015.

17.

MRI-based brain atrophy rates in ADNI phase 2: acceleration and enrichment considerations for clinical trials.

Hua X, Ching CR, Mezher A, Gutman BA, Hibar DP, Bhatt P, Leow AD, Jack CR Jr, Bernstein MA, Weiner MW, Thompson PM; Alzheimer's Disease Neuroimaging Initiative..

Neurobiol Aging. 2016 Jan;37:26-37. doi: 10.1016/j.neurobiolaging.2015.09.018. Epub 2015 Oct 19.

18.

A potential endophenotype for Alzheimer's disease: cerebrospinal fluid clusterin.

Deming Y, Xia J, Cai Y, Lord J, Holmans P, Bertelsen S, Holtzman D, Morris JC, Bales K, Pickering EH, Kauwe J, Goate A, Cruchaga C; Alzheimer's Disease Neuroimaging Initiative..

Neurobiol Aging. 2016 Jan;37:208.e1-9. doi: 10.1016/j.neurobiolaging.2015.09.009. Epub 2015 Sep 25.

19.

Trajectories of Neuropsychiatric Symptoms and Cognitive Decline in Mild Cognitive Impairment.

David ND, Lin F, Porsteinsson AP; Alzheimer's Disease Neuroimaging Initiative..

Am J Geriatr Psychiatry. 2016 Jan;24(1):70-80. doi: 10.1016/j.jagp.2015.06.001. Epub 2015 Jun 27.

20.

Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression.

Zetterberg H, Skillbäck T, Mattsson N, Trojanowski JQ, Portelius E, Shaw LM, Weiner MW, Blennow K; Alzheimer’s Disease Neuroimaging Initiative..

JAMA Neurol. 2016 Jan;73(1):60-7. doi: 10.1001/jamaneurol.2015.3037.

PMID:
26524180

Supplemental Content

Loading ...
Support Center